In early February, the HDG team attended its home state LeadingAge conference, the LeadingAge Minnesota Institute & Expo. The Institute is always a great time to learn, connect with friends and colleagues, and share what we learn in our own communities and in working with providers from coast to coast. Interest in PDPM outcomes is strong as evidenced by the attendance for The Real Truth of PDPM – Early Learnings for Senior Leadership session that I presented. Following is a summary of the presentation.
The Patient-Driven Payment Model (PDPM) was live on October 1, 2019, and it was a mad rush to the finish line! Just prior to October 1, some glitches were found with the Centers for Medicare and Medicaid Services (CMS) PDPM grouper. These glitches impacted the ability to successfully complete the MDS generating a HIPPS code, and submission of Interim Payment Assessments (IPAs) was put on hold. Known issues around HIPPS codes, interrupted stays, and transitional IPAs were identified. There were also updates to the final grouper logic and submission technology.
In addition, right before and after the go-live date, many Medicare Advantage plans adopted PDPM, especially if they previously paid based on RUGs. Notice to providers was lacking in some cases, or provided very late, and the lack of provider guidance resulted in duplication of assessments to ensure that reimbursement was not lost. In some cases, authorizations are being provided for a low PDPM rate prior to submission of the MDS.
In early October, the Medicare claims processing manual was released with an effective date of November 5, 2019.
Early indications for financial performance under PDPM have been positive for many providers, likely due to a Non-Therapy Ancillary (NTA) bump for all patients on Medicare Part A caseload as of October 1 (300 percent of NTA component for October 1–3). Other factors include increased attention to payment-sensitive items and clinical service line development.
However, before you throw a party, remember that the NTA jump at the start of PDPM is a one-time event with a 4 percent increase, and PDPM was designed to be revenue neutral—adjustments will follow.
While the transition has gone well for most providers, and many are seeing strong financial indicators, we are observing several common challenges among providers, including:
For challenges with IPAs, we offer the following guidance: IPAs are optional, and CMS states, “we note that while a SNF’s decision to complete the IPA itself is indeed optional, the SNF’s underlying responsibility to remain fully aware of (and respond appropriately to) any changes in its resident’s condition is in no way discretionary.” The entire interdisciplinary team (IDT) should carefully review IPAs to determine payment for all components before proceeding. Also remember that IPAs cannot be combined with any other MDS assessments.
Other changes are expected, including a proposal by CMS that section G be eliminated from all federal MDS item sets effective October 1, 2020, in an effort to reduce duplicative paperwork. Individual states may use the Optional State Assessment, and we expect this may cause states to reconsider Medicaid case-mix strategies.
As previously mentioned, PDPM was created to be budget neutral, and there will be increased scrutiny by CMS, OIG, and MedPAC of financial and clinical outcomes under new payment models. This will include analysis of coding creep, payment weight recalibration, and margins analysis.
As we continue to work in a PDPM world and see ongoing changes and adjustments, there are several key areas that providers must focus on. Operational processes must be well documented and followed and should include:
In addition, clinical coding accuracy and documentation audits should be completed to confirm that payment-sensitive items (e.g., SLP and NTA comorbidities) are accurately and completely captured.
As we moved toward October 1, 2019, there was much last-minute scrambling to sign therapy contracts. Many contracts pay based on a percentage of PDPM therapy components, and some pay based on a percentage of the total rate. There are pros and cons to each approach. Most providers initially reported few day-to-day changes, but they need to really look at the data. Many of the contract terms included an early 2020 review, and now is the time. These reviews should include:
Ultimately, SNFs should move their contracts or in-house compensation to a value-based structure, adjusting some portion of the payment for quality outcomes and processes.
HDG can help providers seize opportunities and address challenges as the new payment system continues to evolve. Our solutions include education and training, clinical coding and reimbursement auditing, benchmarking and rate projections, clinical service line development, and more. Please call or email us at 763.537.5700 or email@example.com and visit our website.
Erin Shvetzoff Hennessey
CEO, Health Dimensions Group